Press Release
Global Sleeping Aids Market is estimated to reach $96 billion by 2024, Says Variant Market Research
 Published Date:  Sep 2017  Publish By: Variant Market Research

Global Sleeping Aids Market Report, published by Variant Market Research, forecast that the global market is expected to reach $96 Billion by 2024 from $59 Billion in 2016, growing at a CAGR of 6.3% from 2016 to 2024. By geography, Asia Pacific and RoW are expected to grow at a CAGR of 7.9% and 6.7%, respectively, during the forecast period.

"Sleeping Aids Market (By Product Type: Mattresses and Pillows, Sleep Laboratories, Medication, Sleep Apnea Devices; By Sleep Disorder: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024"

To browse the complete report, visit at: https://www.variantmarketresearch.com/report-categories/pharmaceuticals/sleeping-aids-market

The factors driving the growth of the global sleeping aids marketare increasing disposable income, changing consumer lifestyle, rise in demand for sleeping pills, and increase in geriatric and obese population. Additionally, rising awareness about sleeping disorders, and advanced technologies would provide several market opportunities in future years. Though, various side effects of sleep aids medication and patent expiration may limit the growth of the market.  

Product type, sleep disorder, and geography are the key segments considered in the global sleeping aids market. By product type, the market is categorized into mattresses and pillows, sleep laboratories, medication (prescription based drugs, herbal drugs, OTC drugs), sleep apnea devices and others. Among which, mattresses and pillows held the largest market share in 2016, followed by sleep laboratories. Further, by sleep disorder the market is categorized into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking, and other sleep disorders. Among which, insomnia held the largest market share in 2016, followed by sleep apnea.

By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America accounted for the largest market share in 2016. Moreover, in terms of growth, Asia-Pacific is expected to grow with fastest CAGR of 7.9% during the forecast period 2016 to 2024, driven by, rising geriatric population and, increase in demand for sleeping pills.

Major companies operating in this market comprises of Pfizer, Takeda Pharmaceutical Company Limited, CareFusion Corporation, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Limited, Compumedics Limited, Merck And Co., Sanofi, Serta International, and Natus Medical Incorporated among others.

Contact Us:

John Dave,
Head - Sales 
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: john.dave@variantmarketresearch.com 
Email: help@variantmarketresearch.com


GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Sleeping Aids Market by product: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Mattresses and Pillows
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Sleep Laboratories
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Medication
          4.3.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
          4.4.3 Prescription Based Drugs
                  4.4.3.1 Market Size and Forecast
          4.4.4 Herbal Drugs
                  4.4.4.1 Market Size and Forecast
          4.4.5 OTC Drugs
                  4.4.5.1 Market Size and Forecast
    4.5 Sleep Apnea Devices
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
    4.6 Other Products
          4.6.1 Current Trend and Analysis
          4.6.2 Market Size and Forecast
Chapter 5 Sleeping Aids Market by Sleep Disorder: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Insomnia
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Sleep Apnea
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
    5.4 Restless Legs Syndrome
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
    5.5 Narcolepsy
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
    5.6 Sleep Walking
          5.6.1 Current Trend and Analysis
          5.6.2 Market Size and Forecast
    5.7 Other Sleep Disorders
          5.7.1 Current Trend and Analysis
          5.7.2 Market Size and Forecast
Chapter 6 Sleeping Aids Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 US
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 Germany
                   6.3.3.1 Market Size and Forecast
          6.3.4 France
                   6.3.4.1 Market Size and Forecast
          6.3.5 United Kingdom
                   6.3.5.1 Market Size and Forecast
          6.3.6 Italy
                   6.3.6.1 Market Size and Forecast
          6.3.7 Others
                   6.3.7.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 China
                   6.4.3.1 Market Size and Forecast
          6.4.4 India
                   6.4.4.1 Market Size and Forecast
          6.4.5 Japan
                   6.4.5.1 Market Size and Forecast
          6.4.6 South Korea
                   6.4.6.1 Market Size and Forecast
          6.4.7 Others
                   6.4.7.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 South America
                   6.5.3.1 Market Size and Forecast
          6.5.4 Middle East
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 Takeda Pharmaceutical Company Limited
    7.2 CareFusion Corporation
    7.3 Pfizer
    7.4 Teva Pharmaceutical Industries Limited
    7.5 Natus Medical Incorporated
    7.6 Compumedics Limited
    7.7 Merck And Co.
    7.8 Sanofi
    7.9 GlaxoSmithKline Plc
    7.10 Serta International

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha